James Dean Vogel, P.E., the Founder and Director of The BioProcess Institute, has more than 25 years of experience in the biopharmaceutical, food and cosmetic industries. His consulting expertise lies in all areas of our business: engineering, management, and cGMP regulatory. He helps all levels or organizations from corporate executives to on-the-floor personnel to address their issues and work to their potential. He has consulted in numerous single-use applications from facility retrofits and run-rate improvements to designing processes from scratch. Jim has troubleshooted plant operations for both process and utilities and has helped with organizational structures and staff development. One key area is performing risk assessments for both operational as well as engineering systems.
He has worked as a Director, Project Manager, and Engineer (Plant Support, Process Development, Project and Automation), with Amgen, GlaxoSmithKline, ImClone, Sanofi-Pasteur, Lipton and Avon. He was the lead designer for a $700 million large scale BioPharmaceutical plant, and directed numerous facility renovations including upgrades to the buildings, process equipment, utilities, and laboratories.
Mr. Vogel is an Adjunct Professor at Stevens Institute of Technology, leader of programs at the University of Rhode Island, a member of the American Society of Mechanical Engineers (ASME) BioProcess Equipment (BPE) Standard Committee, Chairman of the ASME BPE Sealing Components Subcommittee, a member of the International Society of Pharmaceutical Engineers (ISPE) Disposables Community of Practice Steering Committee, the chairman of the BPSA’s End-User Subcommittee, a member of the NHAAD Hose Safety Institute Advisory Council, and a member of the PDA.
He is a licensed professional engineer in NJ, has a Masters of Engineering in Chemical Engineering from Manhattan College and a Bachelors of Science in BioChemical Engineering from Rutgers University.